hBD-1 vs CJC-1295
Head-to-head comparison of hBD-1 (Human beta-defensin 1) and CJC-1295 (Growth Hormone Releasing Hormone Analog) — benefits, dosing, side effects, research data, and where to buy.
| Property | hBD-1 | CJC-1295 |
|---|---|---|
| Category | Dental & Oral | Performance |
| Full Name | Human beta-defensin 1 | Growth Hormone Releasing Hormone Analog |
| Molecular Weight | 4490 Da | 3,367.97 Da |
| Half-Life | minutes to hours | ~6-8 days (DAC) |
| Amino Acids | 36 | 30 |
| Typical Dose | 1-10 µg/mL in experimental studies | 1-2 mg/week |
| Route | Topical/Intraoral | SC |
| Purity | ≥98% | — |
| Studies Count | 85 | 167 |
| Research Status | Pre-clinical | Clinical Trials |
hBD-1 Benefits
- ✓oral innate immunity
- ✓broad antimicrobial activity
- ✓biofilm suppression
- ✓periodontal support
CJC-1295 Benefits
- ✓Sustained GH release over days
- ✓Improved body composition
- ✓Enhanced deep sleep quality
- ✓Accelerated recovery from training
- ✓Increased protein synthesis
hBD-1 Dosing
topical peptide exposure|cell-culture or mucosal models|repeat low-dose application in research
CJC-1295 Dosing
Without DAC: 100-200 mcg SC 2-3 times daily|With DAC: 1-2 mg SC once or twice weekly|Combined with Ipamorelin: 100 mcg each, 2-3x daily
hBD-1 Side Effects
- ⚠protease degradation
- ⚠local irritation at high dose
- ⚠limited stability in saliva
CJC-1295 Side Effects
- ⚠Common (Mild): Water retention, tingling/numbness, flushing
- ⚠Moderate: Joint stiffness, carpal tunnel-like symptoms
- ⚠Rare: Elevated blood sugar (transient)
Research Overview
hBD-1
hBD-1 has been studied as part of the oral mucosal defense system and is linked to host resistance against dental pathogens. Research spans periodontitis, candidiasis, and epithelial barrier biology.
CJC-1295
CJC-1295 has good pre-clinical and early clinical data. The DAC variant shows sustained GH elevation for days. Often combined with GHRPs for synergistic GH release.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.